The Antiphospholipid Syndrome in the Pediatric Population

Advances in Pediatrics(2022)

Cited 0|Views4
No score
Abstract
Pediatric antiphospholipid syndrome (APS) is characterized by autoantibodies directed against protein complexes on cellular membranes and leads to a prothrombotic, proinflammatory state. A child with APS may present with venous, arterial, or small vessel thrombosis. Other manifestations of APS include nonthrombotic manifestations, such as hematologic and neurologic symptoms. APS may be a primary condition or related to other autoimmune diseases. If APS-related thrombosis is unrecognized, the child may suffer recurrent thrombotic events after the withdrawal of anticoagulation. Thus, it is important to consider APS as a cause of thrombosis in children. Appropriate testing confirms the diagnosis and directs further care.
More
Translated text
Key words
Antiphospholipid antibodies (aPL),Antiphospholipid syndrome (APS),Procoagulant state,Hypercoagulability,Thromboembolism,Thrombosis,Bleeding diathesis,Chronic/recurrent
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined